UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 13.366

Sortiert nach

Characterization of nonlinear spin-wave interference by reservoir-computing metrics

Applied physics letters, 2021-09, Vol.119 (11)

2021

Volltextzugriff (PDF)

Dupilumab: A review of its use in the treatment of atopic dermatitis

Journal of the American Academy of Dermatology, 2018-03, Vol.78 (3), p.S28-S36

2018

Volltextzugriff (PDF)

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

The New England journal of medicine, 2016-07, Vol.375 (4), p.345-356

2016

Volltextzugriff (PDF)

Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study

British journal of dermatology (1951), 2013-02, Vol.168 (2), p.412-421

2013

Volltextzugriff (PDF)

Spin-wave based realization of optical computing primitives

Journal of applied physics, 2014-05, Vol.115 (17)

2014

Volltextzugriff (PDF)

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study

Journal of the American Academy of Dermatology, 2016-05, Vol.74 (5), p.841-850

2016

Volltextzugriff (PDF)

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial

Journal of the American Academy of Dermatology, 2017-03, Vol.76 (3), p.405-417

2017

Volltextzugriff (PDF)

Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review

Cardiovascular therapeutics, 2019, Vol.2019, p.8295054-9

2019

Volltextzugriff (PDF)

Waxholm Space atlas of the Sprague Dawley rat brain

NeuroImage (Orlando, Fla.), 2014-08, Vol.97, p.374-386

2014

Volltextzugriff (PDF)

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

The Lancet (British edition), 2017-07, Vol.390 (10091), p.276-288

2017

Volltextzugriff (PDF)

Bimekizumab versus Adalimumab in Plaque Psoriasis

The New England journal of medicine, 2021-07, Vol.385 (2), p.130-141

2021

Volltextzugriff (PDF)

European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC

Journal of the European Academy of Dermatology and Venereology, 2015-12, Vol.29 (12), p.2277-2294

2015

Volltextzugriff (PDF)

Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up

British journal of dermatology (1951), 2013-04, Vol.168 (4), p.844-854

2013

Volltextzugriff (PDF)

Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial

British journal of dermatology (1951), 2016-11, Vol.175 (5), p.902-911

2016

Volltextzugriff (PDF)

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study

British journal of dermatology (1951), 2012-09, Vol.167 (3), p.668-677

2012

Volltextzugriff (PDF)

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

The New England journal of medicine, 2016-08, Vol.375 (5), p.422-434

2016

Volltextzugriff (PDF)

Incisional negative pressure therapy reduces complications and costs in pressure ulcer reconstruction

International wound journal, 2019-04, Vol.16 (2), p.394-400

Papp, Anthony A.

2019

Volltextzugriff (PDF)

Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)

Journal of the American Academy of Dermatology, 2017-08, Vol.77 (2), p.310-317.e1

2017

Volltextzugriff (PDF)

A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis

British journal of dermatology (1951), 2016-08, Vol.175 (2), p.273-286

2016

Volltextzugriff (PDF)

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials

British journal of dermatology (1951), 2015-10, Vol.173 (4), p.949-961

2015

Volltextzugriff (PDF)

Clinical meaningfulness of complete skin clearance in psoriasis

Journal of the American Academy of Dermatology, 2016-07, Vol.75 (1), p.77-82.e7

2016

Volltextzugriff (PDF)

A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis

British journal of dermatology (1951), 2016-06, Vol.174 (6), p.1266-1276

2016

Volltextzugriff (PDF)

Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics

Journal of the American Academy of Dermatology, 2013-11, Vol.69 (5), p.729-735

2013

Volltextzugriff (PDF)

Monascus orange and red pigments production by Monascus purpureus ATCC16436 through co-solid state fermentation of corn cob and glycerol: An eco-friendly environmental low cost approach

PloS one, 2018-12, Vol.13 (12), p.e0207755-e0207755

2018

Volltextzugriff (PDF)

Profiling Solute Carrier Transporters in the Human Blood-Brain Barrier

Clinical pharmacology and therapeutics, 2013-12, Vol.94 (6), p.636-639

2013

Volltextzugriff (PDF)

1 – 25 von 13.366

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10.516)
Mit Volltextzugriff
(11.070)

Publikationsform

8 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect
(5.516)
MEDLINE
(5.025)
EZB Electronic Journals Library
(4.909)
Journals@Ovid Complete
(3.242)
Elsevier ScienceDirect Journals Complete
(2.562)
IngentaConnect Journals
(2.034)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.858)
Wiley Online Library - AutoHoldings Journals
(1.588)
Single Journals
(1.585)
Springer Nature - Complete Springer Journals
(1.128)
Wiley Online Library Full Collection 2018
(1.005)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(700)
Oxford University Press Journals Current
(551)
Jstor Complete Legacy
(425)
Ebook Central Perpetual and DDA
(396)
IEEE Xplore
(355)
Taylor & Francis Current Content Access
(346)
eBooks on EBSCOhost
(344)
Oxford Journals 2020 Medicine
(325)
Taylor & Francis:Master (3349 titles)
(317)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Characterization of nonlinear spin-wave interference by reservoir-computing metrics

Dupilumab: A review of its use in the treatment of atopic dermatitis

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study

Spin-wave based realization of optical computing primitives

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial

Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review

Waxholm Space atlas of the Sprague Dawley rat brain

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

Bimekizumab versus Adalimumab in Plaque Psoriasis

European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC

Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up

Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

Incisional negative pressure therapy reduces complications and costs in pressure ulcer reconstruction

Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)

A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials

Clinical meaningfulness of complete skin clearance in psoriasis

A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis

Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics

Monascus orange and red pigments production by Monascus purpureus ATCC16436 through co-solid state fermentation of corn cob and glycerol: An eco-friendly environmental low cost approach

Profiling Solute Carrier Transporters in the Human Blood-Brain Barrier

Suchergebnisse filtern